Investor Webinar - Prof. Catherine Hill and CEO Tim Grogan
Filed with ASX · · 36 pages · English
Bio-Gene Technology Limited (ASX: BGT, ‘Bio-Gene’ or ‘the ‘Company’), an agtech development company enabling the next generation of novel insecticides, is pleased to provide, for the information of shareholders and investors, today’s webcast presentations by Professor Catherine Hill (Head of the Department of Entomology at Purdue University, University in Indiana (USA) and the updated corporate pr
Bio-Gene Technology Ltd. on 6ix
In the deck
Earlier from Bio-Gene Technology
- BGT Corporate Presentation
- BGT 2023AGM - CEO's Presentation
- BGT 2023AGM - CEO's Address
- BGT 2023AGM - Chairman's Address
- Result of Share Purchase Plan Offer (SPP)
Later from Bio-Gene Technology
- Bio-Gene Receives R&D Tax Incentive
- Appendix 4C - 31 December 2023
- Appendix 4D - Half Year Accounts - 31 December 2023
- Investor Webinar - FY24 Half Year Review
- APVMA Pre Application Assistance
Follow Bio-Gene Technology into a list and get an email when it puts out news.
Follow Bio-Gene Technology